Author:
Shadfar Sina,Hwang Chul Ju,Lim Mi-Sun,Choi Dong-Young,Hong Jin Tae
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference161 articles.
1. Aisen, P.S., K.A. Schafer, M. Grundman, E. Pfeiffer, M. Sano, K.L. Davis, M.R. Farlow, S. Jin, R.G. Thomas, and L.J. Thal. 2003. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: A randomized controlled trial. Journal of the American Medical Association 289: 2819–2826.
2. Alaynick, W.A. 2008. Nuclear receptors, mitochondria and lipid metabolism. Mitochondrion 8: 329–337.
3. Alexandrov, P.N., P. Dua, J.M. Hill, S. Bhattacharjee, Y. Zhao, and W.J. Lukiw. 2012. microRNA (miRNA) speciation in Alzheimer’s disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). International Journal of Biochemistry and Molecular Biology 3: 365–373.
4. Alexandrov, P.N., P. Dua, and W.J. Lukiw. 2014. Up-Regulation of miRNA-146a in progressive, age-related inflammatory neurodegenerative disorders of the human CNS. Frontiers in Neurology 5: 181.
5. Andersen, K., L.J. Launer, A. Ott, A.W. Hoes, M.M. Breteler, and A. Hofman. 1995. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer’s disease? The Rotterdam study. Neurology 45: 1441–1445.
Cited by
115 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献